Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Uterine Cancer
100%
Diseases
65%
Tumor
52%
Recurrent Disease
51%
Neoplasm
50%
Krukenberg Tumor
47%
Ovarian Cancer
33%
Pelvis
28%
Endometrium Carcinoma
24%
Retroperitoneal Lymph Node Dissection
23%
Lymph Node
23%
Cancer
21%
Malignant Neoplasm
21%
Overall Survival
18%
Protein P53
17%
Chemotherapy
16%
Progression Free Survival
16%
Adjuvant Therapy
16%
Prognostic Factor
15%
Metastatic Carcinoma
15%
Histology
14%
Ovarian Tumor
14%
Immunohistochemistry
14%
Breast Cancer
13%
Hazard Ratio
13%
Sentinel Lymph Node
13%
Hysterectomy
12%
Lymph Duct
11%
Ploidy
11%
Adenocarcinoma
10%
Morphology
10%
Clear Cell
10%
Lymph Node Metastasis
9%
Radiation Therapy
9%
Cervix
9%
Paraaortic Lymph Node
9%
Median Follow Up
9%
Fluorescence in Situ Hybridization
9%
Genetics
8%
Endometrium
8%
Minimal Residual Disease
8%
Surgery
8%
Progesterone Receptor
8%
Biological Marker
7%
Receptor Expression
7%
Adjuvant Radiotherapy
7%
Prevalence
7%
Serous Carcinoma
7%
Disease Specific Survival
7%
Melanoma
7%
Keyphrases
Endometrial Cancer
58%
Tumor
54%
Ovarian Cancer
19%
Adjuvant Therapy
14%
Epithelial Ovarian Cancer
13%
Human Epidermal Growth Factor Receptor 2 (HER2)
13%
Endometrioid
12%
Endometrial Carcinoma
12%
Histological Subtypes
12%
Lymphadenectomy
11%
Mayo Clinic
11%
Overall Survival
11%
Ovarian Tumor
11%
Uterine Serous Carcinoma
11%
Prognostic Factors
10%
Cervical Carcinoma
10%
Frozen Section
10%
Risk Factors
10%
Hysterectomy
9%
Progression-free Survival
9%
Overexpression
9%
Breast Cancer
9%
Hazard Ratio
8%
Epithelial Ovarian Carcinoma
8%
Metastasis
8%
Breast
8%
Endometrioid Endometrial Cancer
8%
High Risk
8%
P53 Expression
8%
Ovarian Carcinoma
7%
Fluorescence in Situ Hybridization
7%
Flow Cytometric
7%
Non-endometrioid
7%
Sentinel Lymph Node
7%
Disease-specific Survival
7%
Prognostic Indicator
7%
Odds Ratio
7%
Malignancy
7%
DNA Ploidy
7%
Low Risk
6%
5-year Survival
6%
Atypical Hyperplasia
6%
Reoperation
6%
Lymph Node Metastasis
6%
95% Confidence Interval
6%
Proliferative Index
6%
Residual Disease
6%
Multivariate Analysis
6%
Female Genital Tract
6%
Lymph Node
6%